Altimmune, Inc. (ALT) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 26K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 37K | 362K | 6K |
| Revenue Growth % | -100% | 420% | 0% | 0% | 0% | -86.49% | -98.62% | -16.67% | -76.19% | 133.64% | 18000% | -25% |
| Cost of Goods Sold | 23K | 0 | 14.96M | 0 | 0 | 0 | 0 | 0 | 107K | 0 | 18.39M | 13.25M |
| COGS % of Revenue | - | - | 299200% | - | - | - | - | - | 2140% | - | 5079.56% | 220883.33% |
| Gross Profit | -23K | 26K | -14.96M | 5K | 5K | 5K | 5K | 5K | -102K | 37K | -18.03M | -13.25M |
| Gross Margin % | - | 100% | -299100% | 100% | 100% | 100% | 100% | 100% | -2040% | 100% | -4979.56% | -220783.33% |
| Gross Profit Growth % | -560% | 420% | -299200% | 0% | 104.9% | -86.49% | 100.03% | 100.04% | -585.71% | 100.19% | 11.03% | -165687.5% |
| Operating Expenses | 24.22M | 28.92M | 5.9M | 22.93M | 21.82M | 24.87M | 24.77M | 26.75M | 26.69M | 33.66M | 4.51M | 4.76M |
| OpEx % of Revenue | - | 111226.92% | 118080% | 458540% | 436400% | 497420% | 495440% | 535000% | 533840% | 90972.97% | 1246.96% | 79333.33% |
| Selling, General & Admin | 8.05M | 10.51M | 5.9M | 5.69M | 5.99M | 5.09M | 4.97M | 5.59M | 5.31M | 4.33M | 4.51M | 4.76M |
| SG&A % of Revenue | - | 40423.08% | 118080% | 113820% | 119860% | 101800% | 99380% | 111900% | 106240% | 11708.11% | 1246.96% | 79333.33% |
| Research & Development | 16.17M | 18.41M | 14.96M | 17.24M | 15.83M | 19.78M | 19.8M | 21.16M | 21.49M | 16.91M | 18.39M | 13.25M |
| R&D % of Revenue | - | 70803.85% | 299200% | 344720% | 316540% | 395620% | 396060% | 423100% | 429740% | 45700% | 5079.56% | 220883.33% |
| Other Operating Expenses | 0 | 0 | -1000K | 0 | 0 | 0 | 0 | 0 | -107K | 1000K | -1000K | -1000K |
| Operating Income | -24.24M | -28.89M | -20.86M | -22.92M | -21.82M | -24.87M | -24.77M | -26.75M | -26.79M | -33.62M | -22.54M | -18.01M |
| Operating Margin % | - | -111126.92% | -417180% | -458440% | -436300% | -497320% | -495340% | -534900% | -535880% | -90872.97% | -6226.52% | -300116.67% |
| Operating Income Growth % | -11.13% | -16.19% | 15.78% | 14.29% | 18.58% | 26.04% | -9.88% | -48.53% | -23.14% | -45.59% | 8.94% | 11.71% |
| EBITDA | -24.22M | -28.87M | -20.83M | -22.89M | -21.79M | -24.83M | -24.73M | -26.68M | -26.69M | -31.73M | -22.42M | -17.88M |
| EBITDA Margin % | - | -111026.92% | -416640% | -457840% | -435720% | -496660% | -494600% | -533680% | -533740% | -85764.86% | -6193.09% | -298033.33% |
| EBITDA Growth % | -11.18% | -16.24% | 15.76% | 14.21% | 18.36% | 21.74% | -10.31% | -49.22% | -23.36% | -40.21% | 9.39% | 12.09% |
| D&A (Non-Cash Add-back) | 23K | 26K | 27K | 30K | 29K | 33K | 37K | 61K | 107K | 1.89M | 121K | 125K |
| EBIT | -24.24M | -28.89M | -18.52M | -21.88M | -20.25M | -23.18M | -22.84M | -24.64M | -24.39M | -31.64M | -22.54M | -18.01M |
| Net Interest Income | 1.83M | 1.56M | 1.93M | 868K | 1.54M | 1.57M | 1.9M | 2.18M | 2.41M | 1.96M | 1.85M | 1.83M |
| Interest Income | 2.9M | 2.44M | 2.43M | 1.13M | 1.54M | 1.57M | 1.91M | 2.18M | 2.41M | 1.96M | 1.88M | 1.83M |
| Interest Expense | 1.07M | 876K | 495K | 264K | 1K | 1K | 6K | 1K | 1K | 2K | 29K | 2K |
| Other Income/Expense | 1.68M | 1.53M | 1.84M | 776K | 1.56M | 1.69M | 1.92M | 2.1M | 2.4M | 1.98M | 1.87M | 1.95M |
| Pretax Income | -22.56M | -27.36M | -19.01M | -22.15M | -20.26M | -23.18M | -22.84M | -24.64M | -24.39M | -31.64M | -20.67M | -16.06M |
| Pretax Margin % | - | -105223.08% | -380280% | -442920% | -405120% | -463600% | -456900% | -492800% | -487880% | -85516.22% | -5710.22% | -267683.33% |
| Income Tax | 0 | 0 | 0 | 0 | -681K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 3.36% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -22.56M | -27.36M | -19.01M | -22.15M | -19.57M | -23.18M | -22.84M | -24.64M | -24.39M | -31.64M | -20.67M | -16.06M |
| Net Margin % | - | -105223.08% | -380280% | -442920% | -391500% | -463600% | -456900% | -492800% | -487880% | -85516.22% | -5710.22% | -267683.33% |
| Net Income Growth % | -15.26% | -18.02% | 16.77% | 10.12% | 19.75% | 26.74% | -10.52% | -53.42% | -21.52% | -46.08% | 12.1% | 20.12% |
| Net Income (Continuing) | -22.56M | -27.36M | -19.01M | -22.15M | -19.57M | -23.18M | -22.84M | -24.64M | -24.39M | -31.64M | -20.67M | -16.06M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.18 | -0.27 | -0.21 | -0.27 | -0.26 | -0.33 | -0.32 | -0.35 | -0.34 | -0.54 | -0.39 | -0.32 |
| EPS Growth % | 30.77% | 18.18% | 34.38% | 22.86% | 23.53% | 38.89% | 17.95% | -9.38% | 8.11% | -35% | 18.75% | 23.81% |
| EPS (Basic) | -0.18 | -0.27 | -0.21 | -0.27 | -0.26 | -0.33 | -0.32 | -0.35 | -0.34 | -0.54 | -0.39 | -0.32 |
| Diluted Shares Outstanding | 124.46M | 100.61M | 89.42M | 81.48M | 75.55M | 71.26M | 71.08M | 70.92M | 70.8M | 58.44M | 53.63M | 50.69M |
| Basic Shares Outstanding | 124.46M | 100.61M | 89.42M | 81.48M | 75.55M | 71.26M | 71.08M | 70.92M | 70.8M | 58.25M | 53.63M | 50.69M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |